Skip to main content
. Author manuscript; available in PMC: 2017 Sep 15.
Published in final edited form as: Breast Cancer Res Treat. 2016 Jul 25;159(1):31–39. doi: 10.1007/s10549-016-3917-6

Table 4.

Comparison of Her-2 equivocal results by IHC and by D-FISH per the 2013 ASCO/CAP guidelines

IHC (ASCO 2013) Equivocal versus Others

Negative (0&1+) Equivocal( 2+) Positive (3+) Total Mcnemar Kappa
FISH (ASCO 2013) Negative 108(42.4) 58(22.7) 1(0.4) 167(65.5) P<0.001 P=0.771
Equivocal 20(7.8) 12(4.7) 1(0.4) 33(12.9)
Positive 5(2.0) 17(6.7) 33(12.9) 55(21.6)
Total 133(52.2) 87(34.1) 35(13.7) 255(100.0)

Her-2 D-FISH: Her-2 dual-probe fluorescent in situ hybridization

IHC: Immunohistochemistry